BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 12030427)

  • 1. The association between systemic lupus erythematosus and deficiencies of the complement system.
    Goerg S
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):237-45. PubMed ID: 12030427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.
    Zachrau B; Finke D; Kropf K; Gosink HJ; Kirchner H; Goerg S
    Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement deficiencies and systemic lupus erythematosus.
    Truedsson L; Bengtsson AA; Sturfelt G
    Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement deficiencies in humans and animals: links to autoimmunity.
    Lewis MJ; Botto M
    Autoimmunity; 2006 Aug; 39(5):367-78. PubMed ID: 16923536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of endogenous apoptotic DNA and IFN-alpha in complement C4-deficient mice: implications for induction of systemic lupus erythematosus.
    Finke D; Randers K; Hoerster R; Hennig H; Zawatzky R; Marion T; Brockmann C; Klempt-Giessing K; Jacobsen K; Kirchner H; Goerg S
    Eur J Immunol; 2007 Jun; 37(6):1702-9. PubMed ID: 17506029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus.
    Cook HT; Botto M
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):330-7. PubMed ID: 16932712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary immunodeficiency and autoimmunity: lessons from human diseases.
    Arason GJ; Jorgensen GH; Ludviksson BR
    Scand J Immunol; 2010 May; 71(5):317-28. PubMed ID: 20500682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complement system in systemic lupus erythematosus.
    Sturfelt G
    Scand J Rheumatol; 2002; 31(3):129-32. PubMed ID: 12195625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protective role for innate immunity in systemic lupus erythematosus.
    Carroll MC
    Nat Rev Immunol; 2004 Oct; 4(10):825-31. PubMed ID: 15459673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus conundrums.
    Wardle EN
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):731-6. PubMed ID: 19736466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
    Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
    Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.
    Mevorach D
    Apoptosis; 2010 Sep; 15(9):1114-23. PubMed ID: 20683667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
    Arason GJ; Steinsson K; Kolka R; Víkingsdóttir T; D'Ambrogio MS; Valdimarsson H
    Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical aspects of the complement system].
    Tsukamoto H; Horiuchi T
    Rinsho Byori; 2006 Jul; 54(7):757-62. PubMed ID: 16913667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell biology: implications for treatment of systemic lupus erythematosus.
    Anolik JH
    Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the relationship between complement and systemic lupus erythematosus?
    Podrebarac TA; Goldstein R
    J Rheumatol; 1998 Nov; 25(11):2062-4. PubMed ID: 9818645
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions.
    Erdei A; Isaák A; Török K; Sándor N; Kremlitzka M; Prechl J; Bajtay Z
    Mol Immunol; 2009 Sep; 46(14):2767-73. PubMed ID: 19559484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T
    J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1q, autoimmunity and apoptosis.
    Botto M; Walport MJ
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.